Chemomab Therapeutics Cash Flow Statement (2017-2025) | CMMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	-0.03B	0.01B	0.01B	0.01B	-0.04B	0.00B	0.00B	0.00B	0.00B	377.13B	0.00B	625.68B
Depreciation and Depletion (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)	0.00B		0.00B	-0.00B	0.00B		0.00B	0.00B	0.00B		0.00B	0.00B	-0.00B
Cash from Operations (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B
Change in Accured Expenses (Quarter)	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	-0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B
Investing Activities
Capital Expenditures (Quarter)	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B		0.00B
Sales of Property, Plant and Equipment (Quarter)		0.00B
Cash from Investing Activities (Quarter)	-0.00B	-0.00B	-0.00B	-0.02B	-0.01B	-0.02B	0.00B	0.00B	0.01B	0.01B	0.01B	-0.00B	0.00B	0.00B
Financing Activities
Other financing activities (Quarter)	0.00B	0.00B	0.00B	-0.00B		0.00B		0.00B	0.00B	0.00B			0.00B	-0.01B
Cash from Financing Activities (Quarter)	0.00B	0.00B	0.05B	0.01B	-0.00B	-0.00B		0.00B	0.00B	-0.00B		0.00B	0.00B	0.00B
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)			0.05B										0.00B
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-0.00B	-0.00B	0.05B	-0.01B	-0.01B	-0.02B	-0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	-0.00B	0.00B
Free Cash Flow (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.00B
Net Cash Flow (Quarter)	-0.00B	-0.00B	0.05B	-0.01B	-0.01B	-0.02B	-0.00B	-0.00B	0.00B	0.00B	0.01B	-0.01B	-0.00B	0.00B

Research Tools

Developers

Chemomab Therapeutics Cash Flow Statement (2017-2025) | CMMB

Research Tools

Developers

Chemomab Therapeutics Cash Flow Statement (2017-2025) | CMMB

Create an account

Sign In

Reset Password